Author:
O’Fee Katie,Burley Amy,Wilkins Anna
Reference141 articles.
1. PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism;Adams;Cancer Research,2004
2. Safety of BXCL701, a small molecule inhibitor of dipeptidyl peptidases (DPP), with pembrolizumab, (pembro, anti-PD-1) monoclonal antibody, in men with metastatic castration-resistant prostate cancer (mCRPC);Aggarwal;Journal of Clinical Oncology,2020
3. Phase Ib/II trial of siltuximab and spartalizumab in patients in metastatic pancreatic cancer;Akce;Journal of Clinical Oncology,2022
4. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma;Amann;Cancer Science,2009
5. Cell-specific expression of the FAP gene is regulated by enhancer elements;Antonova;Frontiers in Molecular Biosciences,2023